All trading involves risk. Losses can exceed deposits.

Euro dips after US outlook is raised

The euro is lower versus the US dollar after the US economic outlook was raised by Standard and Poor’s.

All trading involves risk. Losses can exceed deposits.

The euro is trading at $1.3196, down 0.15%, after Standard and Poor’s (S&P) raised their outlook for the US economy from negative to stable. The ratings agency stripped the US of its triple-A rating and lowered its outlook to negative in 2011.  . The credit-rating agency cited the country’s high GDP and expected future growth rates as the reason for upping the outlook, prompting traders to sell the euro and buy the dollar.

Weak economic indicators from the eurozone also pushed EUR/USD lower. The Sentix index, which measures investor confidence in the region, came in at -11.6 in May, against an expected measurement of -10.0. Any negative reading indicates a pessimistic outlook.

Italian industrial production dropped in April, contracting by 0.3% compared with March – the third consecutive monthly drop in industrial production.

Spot FX EUR/USD (DFB) chart

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.